Fortrea Holdings Inc. (FTRE) Q1 2026 Earnings Call Transcript
Fortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimates
Fortrea Reports First Quarter 2026 Results
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?
Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth
Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call
Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials
SG Americas Securities LLC Raises Stock Holdings in Fortrea Holdings Inc. $FTRE
Assenagon Asset Management S.A. Lowers Stock Holdings in Fortrea Holdings Inc. $FTRE
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Fortrea Holdings Inc. $FTRE Shares Sold by Citigroup Inc.
Allianz SE Buys Shares of 48,000 Fortrea Holdings Inc. $FTRE
Fortrea Holdings Inc. (FTRE) Q4 2025 Earnings Call Transcript
Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates
Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance
Fortrea Holdings Inc. (NASDAQ:FTRE) Receives Average Rating of “Hold” from Analysts
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
FTRE vs. PRTA: Which Stock Is the Better Value Option?
Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call
FTRE or ACAD: Which Is the Better Value Stock Right Now?
Fortrea Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE
Fortrea Holdings Inc. (FTRE) Shows Fast-paced Momentum But Is Still a Bargain Stock
Fortrea Holdings Inc. (FTRE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Head to Head Survey: Avalon GloboCare (NASDAQ:ALBT) versus Fortrea (NASDAQ:FTRE)
FTRE vs. ACAD: Which Stock Is the Better Value Option?
Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference
Fortrea Holdings Inc. (FTRE) Moves 5.5% Higher: Will This Strength Last?
Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference
Important Notice to Long-Term Shareholders of Alexandria Real Estate Equities, Inc. (NYSE: ARE); CarMax, Inc. (NYSE: KMX); Fortrea Holdings, Inc. (NASDAQ: FTRE); StubHub Holdings, Inc. (NYSE: STUB): Grabar Law Office Investigates Claims on Your Behalf
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery
Capital Fund Management S.A. Grows Stake in Fortrea Holdings Inc. $FTRE
Fortrea Holdings Inc. (FTRE) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences
Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand
Fortrea Appoints Agnieszka Gallagher as General Counsel
Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); enCore Energy Corp. (NASDAQ: EU); Fortrea Holdings, Inc. (NASDAQ: FTRE); and Stride, Inc. (NYSE: LRN): Grabar Law Office Investigates Claims on Your Behalf
Velocity Clinical Research Appoints Former Fortrea Executive, Andrew Reina, as Chief Revenue Officer
Fortrea Holdings Inc. (FTRE) Q3 2025 Earnings Call Transcript
Fortrea Holdings Inc. (FTRE) Q3 Earnings Lag Estimates
Fortrea Reports Third Quarter 2025 Results
Focus Partners Advisor Solutions LLC Makes New $78,000 Investment in Fortrea Holdings Inc. $FTRE
31,616 Shares in Fortrea Holdings Inc. $FTRE Bought by Brighton Jones LLC
Ethic Inc. Makes New Investment in Fortrea Holdings Inc. $FTRE
Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call
5 Value Picks to Ride Out US-China Trade Rift & Government Shutdown
Fortrea Appoints William Sharbaugh to Board of Directors
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)